EUVIMEDEUVIMED entdecken
Crossref

Mitochonic acid 5 rescues cardiomyocytes from doxorubicin-induced toxicity via repressing the TNF-α/NF-κB/NLRP3-mediated pyroptosis

Wenliang Zha, Qian Zhao, Ye Xiao, Yuanyuan Gan, Junjun Wei, Mengqi Yu, Yanmei Xu, Qiongyao Xu, Shi Wu, Wei Yu

International Immunopharmacology · 2023

DOI: 10.1016/j.intimp.2023.110736 ↗

Kurz gefasst

Fachartikel in der Zeitschrift International Immunopharmacology, 2023. Verfasst von Wenliang Zha und 9 weiteren Autor:innen. Beteiligte Einrichtung: Xianning Medical College, Hubei University of Science and Technology, Xianning 437100, China; Second Affiliated Hospital, Xianning Medical College, H…. Hauptthemen laut MEDLINE: NF-kappa B, Myocytes, Cardiac. Die Arbeit wurde bisher 27-mal zitiert (Crossref) und nennt 51 Literaturangaben.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

AIMS: Doxorubicin (DOX) is an effective anti-tumor drug, but the cardiotoxicity severely limits its clinical use. Interestingly, a hypothesis has emerged suggesting an association between DOX-induced cardiotoxicity and mitochondrial disorders and oxidative stress. The mitochonic acid 5 (MA5) shows promise in alleviating mitochondrial dysfunction by promoting mitochondrial ATP synthesis and reducing reactive oxygen species (ROS) accumulation, though its potential in ameliorating DOX-induced cardiotoxicity remains elusive. METHODS: Network pharmacology approach, molecular docking techniques, and molecular dynamics simulation (MDS) were used to reveal the specific drug targets and pharmaceutical mechanisms involved in the treatment of DOX-induced cardiotoxicity using MA5. For experimental verification, cardiomyocytes (H9c2) and mice were exposed to DOX in the presence or absence of MA5. Our investigation involved the assessment of echocardiographic parameters, cardiac enzymes, inflammatory factors, mitochondrial function, myocardial structure, and cardiomyocyte pyroptosis. RESULTS: Among the 100 core targets identified in network pharmacology, MA5 was pharmacologically active against DOX-induced cardiotoxicity via pathways implicated in cancer, prostate cancer, lipids and atherosclerosis. Molecular docking analysis confirmed that MA5 docked well with TNF-α, interleukin-6 (IL-6), and caspase-3. Furthermore, MA5 exhibited a stronger affinity toward TNF-α than IL-6 and caspase-3. Subsequent MDS revealed the stability of binding between MA5 and TNF-α. The DOX-challenged mice also displayed abnormal myocardial enzymogram, disrupted systolic and diastolic function, and elevated inflammation and cardiomyocyte pyroptosis, which could be mitigated by the administration of MA5. Similarly, H9c2 cells exposed to DOX showed increased intracellular ROS production and impaired mitochondrial function, which were relieved by MA5 treatment. CONCLUSION: Our findings suggest that MA5 attenuates DOX-induced cardiac anomalies through the TNF-α-mediated regulation of inflammation and pyroptosis. These insights offer a potential therapeutic strategy for managing DOX-induced cardiac complications, thereby improving the safety and efficacy of cancer treatments.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

NF-kappa BMyocytes, CardiacMaleMiceAnimalsTumor Necrosis Factor-alphaPyroptosisCaspase 3NLR Family, Pyrin Domain-Containing 3 ProteinCardiotoxicityInterleukin-6Reactive Oxygen SpeciesMolecular Docking SimulationDoxorubicinOxidative StressInflammationApoptosisIndoleacetic AcidsPhenylbutyrates

Stichwörter der Autor:innen

CardiotoxicityDoxorubicinInflammationMitochonic acid 5PyroptosisTumor necrosis factor-alpha

Substanzen

NF-kappa BTumor Necrosis Factor-alphaCaspase 3NLR Family, Pyrin Domain-Containing 3 ProteinInterleukin-6Reactive Oxygen SpeciesDoxorubicin4-(2,4-difluorophenyl)-2-(1H-indol-3-yl)-4-oxobutanoic acidIndoleacetic AcidsPhenylbutyrates

Autor:innen und Institutionen

  • Xianning Medical College, Hubei University of Science and Technology, Xianning 437100, China; Second Affiliated Hospital, Xianning Medical College, Hubei University of Science and Technology, Xianning 437100, China.
  • The Affiliated Hospital of Inner Mongolia Medical University, Huhhot 010000, China.
  • School of Pharmacy, Xianning Medical College, Hubei University of Science and Technology, Xianning 437100, China.
  • The Third People's Hospital of Hubei Province, Wuhan, 430000, China.
  • School of Pharmacy, Xianning Medical College, Hubei University of Science and Technology, Xianning 437100, China. Electronic address: 775209450@qq.com.
  • Xianning Medical College, Hubei University of Science and Technology, Xianning 437100, China; School of Pharmacy, Xianning Medical College, Hubei University of Science and Technology, Xianning 437100, China. Electronic…

Zitieren

APA

Zha, W., Zhao, Q., Xiao, Y., Gan, Y., Wei, J., Yu, M., Xu, Y., Xu, Q., Wu, S., & Yu, W. (2023). Mitochonic acid 5 rescues cardiomyocytes from doxorubicin-induced toxicity via repressing the TNF-α/NF-κB/NLRP3-mediated pyroptosis. International Immunopharmacology. https://doi.org/10.1016/j.intimp.2023.110736

Vancouver

Zha W, Zhao Q, Xiao Y, Gan Y, Wei J, Yu M, et al. Mitochonic acid 5 rescues cardiomyocytes from doxorubicin-induced toxicity via repressing the TNF-α/NF-κB/NLRP3-mediated pyroptosis. International Immunopharmacology. 2023. doi:10.1016/j.intimp.2023.110736

BibTeX
@article{Zha2023,
  author = {Zha, Wenliang and Zhao, Qian and Xiao, Ye and Gan, Yuanyuan and Wei, Junjun and Yu, Mengqi and Xu, Yanmei and Xu, Qiongyao and Wu, Shi and Yu, Wei},
  title = {Mitochonic acid 5 rescues cardiomyocytes from doxorubicin-induced toxicity via repressing the TNF-α/NF-κB/NLRP3-mediated pyroptosis},
  journal = {International Immunopharmacology},
  year = {2023},
  doi = {10.1016/j.intimp.2023.110736}
}
Kostenlos starten →